Product-type market taxonomy separates the landscape into handheld, benchtop, and floor-standing Automatic Blood Bag Tube Thermosealers. Handheld variants, typically <2 kg and powered by Li-ion packs, satisfy field campaigns, military forward hospitals, and mobile donation drives; they command higher ASP/unit owing to battery circuitry and ruggedized housings but remain limited to ≤500 seals per charge. Benchtop models dominate institutional procurements, balancing 1,500–3,000 seals/hour throughput with minimal bench space; cost efficiency is achieved through shared power supplies and standardized heating cartridges. Floor-standing systems target high-volume blood processors, integrating multiple sealing heads, conveyors, and RFID rejection chutes that push throughput above 6,000 seals/hour; their share of total revenue is lower because only tier-1 facilities can absorb the capital outlay and validation burden. Together, the three form factors create a tiered pricing structure that widens addressable market value.